Previous 10 | Next 10 |
Wize Pharma ( OTCQB:WIZP ) has completed enrollment in a Phase 4 clinical trial evaluating eye drop LO2A, branded as EyeCon in Israel, for the symptomatic treatment of dry eye syndrome (DES) in patients with an autoimmune disorder called Sjögren's syndrome (the immune system attacks g...
HOD HASHARON, Israel , Jan. 21, 2020 /PRNewswire/ -- Wize Pharma , Inc. (OTCQB: WIZP) ("Wize"), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced it has completed enrolment in its Phase IV clinical trial of its eye drop for...
HOD HASHARON, Israel , Jan. 16, 2020 /PRNewswire/ -- Wize Pharma , Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced that it has entered into a strategic transaction with Bonus BioGroup Ltd. (TASE: BONS.T...
HOD HASHARON, Israel , Dec. 3, 2019 /PRNewswire/ -- Wize Pharma , Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced it amended the terms of certain convertible loans which had total outstanding amounts of ...
HOD HASHARON, Israel , Sept. 9, 2019 /PRNewswire/ -- Wize Pharma , Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced it has entered into an Exclusive License Agreement with U.S.-based Copernicus Therapeutics...
HOD HASHARON, Israel , July 8, 2019 /PRNewswire/ -- Wize Pharma , Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, announced today that it has retained Lighthouse BioPartners, LLC a US-based firm specialized in partnering and...
HOD HASHARON, Israel , June 28, 2019 /PRNewswire/ -- Wize Pharma , Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, announced today that the Company and Cannabics Pharmaceuticals (OTCQB: CNBX) have together created and adop...
LOS ANGELES , June 14, 2019 /PRNewswire/ -- Wize Pharma, Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced an interview with its CEO, Noam Danenberg , will air on The RedChip Money Report television prog...
HOD HASHARON, Israel , May 21, 2019 /PRNewswire/ -- Wize Pharma , Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today issued a Letter to Shareholder. Dear Fellow Shareholders, We are very pleased to report on o...
HOD HASHARON, Israel , April 30, 2019 /PRNewswire/ -- Wize Pharma , Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced it will present at the ThinkEquity Conference on May 2, 2019 at 2:30 pm ET at the...
News, Short Squeeze, Breakout and More Instantly...
Wize Pharma Inc Company Name:
WIZP Stock Symbol:
OTCMKTS Market:
BEIJING, April 22, 2021 (GLOBE NEWSWIRE) -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced that it entered into a contract to provide 11,760 bitcoin mining machines to Mawson Infrastructure Group Inc. (“...
Point Roberts, WA and Delta, BC - April 21, 2021 (Investorideas.com Newswire) Investorideas.com, a leader in crypto and blockchain investing news brings you today's edition of the Crypto Corner podcast and commentary on what's driving cryptocurrency stocks and the crypto market. Lis...
Wize Pharma to change name to Mawson Infrastructure Group Inc. PR Newswire SYDNEY , March 24, 2021 /PRNewswire/ -- Wize Pharma Inc. (OTCQB: WIZP), following the successful acquisition of Cosmos Capital Limited, a global Digital Infrastructure provider, with ...